NLS Pharmaceutics AG
Biotechnology
Healthcare
NLSP
2.76 M shares
NASDAQ US
traded
23 Sep 2025
listed
no
open
2.17
52 week high
6.04
high
2.20
52 week low
0.00
low
2.07
growth
-65.56 %
previous Close
2.21
P/E ratio
market cap
11.98 M
div yield
0
usd
Mar 2025
qoq
revenue
0.00 %
net incoming
0.00 %
eps
0.00 %
48.97 %
eps surprise
0.00 %
net profit margin
0.00 %
0.00 %
operating incoming
0.00 %
net change in cash
0.00 %
cash on hand
0.00 %
cost of revenue
0.00 %
top top